■月经引起的腹痛(原发性痛经)是一种极为普遍且使人衰弱的症状,影响高达90%的经期个体。
■这项随机对照试验的目的是研究商用经皮神经电刺激装置的效果,TherabodyPowerDot®(TherabodyInc.,洛杉矶)关于痛经与非甾体抗炎药使用的比较。
■这是一项随机交叉研究。
■共有47名参与者同意参与研究,34完成。参与者按随机顺序完成了连续三个月经周期的治疗:单单位经皮神经电刺激(Uno),双单位经皮神经电刺激(Duo),和非甾体抗炎药的使用(对照)。痛经发作后,参与者对其腹部应用经皮神经电刺激至少30分钟.对照参与者被指示根据需要服用非甾体抗炎药。使用调查记录治疗前后的疼痛情况。我们假设PowerDot会降低自我报告的疼痛评分,并减少月经期间非甾体抗炎药的消耗。
■参与者在对照期间经历了统计学和临床上显着的疼痛减轻(-3.52±1.9),Uno(-2.10±1.6),和Duo(-2.19±1.7)个周期(p<0.001)。控制周期内消耗的非甾体抗炎药的剂量(3.5±2.6),与Uno(1.5±3.0)相比有显著差异,或Duo(1.1±2.6)(p=0.004)。
■使用商业经皮神经电刺激装置导致疼痛显著减轻。虽然不像非甾体抗炎药引起的疼痛缓解那么强大,相比之下,经皮神经电刺激的不良事件最小.因此,经皮神经电刺激似乎是缓解痛经疼痛的可行替代方法。
■NCT05178589。
电信号对月经期间疼痛缓解的作用,也被称为时期,是出生时被分配为女性的人的周期性事件。通常,这个时期与腹痛有关,这可能会使许多人衰弱。这种腹痛通常使用非处方药治疗,如布洛芬;然而,有几个注意到的副作用,可以从使用这种药物。因此,本研究旨在了解设备(TherabodyPowerDot®;TherabodyInc.,洛杉矶)向放置在腹部上的垫子发送电流,就像一个加热垫,可用于将期间的疼痛减轻到与药物相似的水平。研究小组研究了三个设置不同的连续时期:一个,细长垫,放在下腹部(Uno),两个圆形垫放在下腹部(Duo),或者不使用设备,只有药物(对照)。研究人员分析了来自34个人的数据。发现所有三个周期都经历了疼痛的显着减少,与Uno和Duo相比,控制周期的疼痛减少更大。这项研究表明,这里使用的电刺激可以大大减少该期间的疼痛,虽然没有药物那么重要。
UNASSIGNED: Abdominal pain due to menses (primary
dysmenorrhea) is an extremely pervasive and debilitating symptom affecting up to 90% of menstruating individuals.
UNASSIGNED: The objective of this randomized control trial was to investigate the effect of a commercial transcutaneous electrical nerve stimulation unit, Therabody PowerDot® (Therabody Inc., Los Angeles) on
dysmenorrhea compared with non-steroidal anti-inflammatory drug use.
UNASSIGNED: This was a randomized cross-over study.
UNASSIGNED: A total of 47 participants agreed to participate in the study, with 34 completing it. Participants completed treatments across three consecutive menstrual cycles in randomized order: single-unit transcutaneous electrical nerve stimulation (Uno), dual unit transcutaneous electrical nerve stimulation (Duo), and non-steroidal anti-inflammatory drug use (Control). Upon onset of
dysmenorrhea, participants applied transcutaneous electrical nerve stimulation to their abdomen for a minimum of 30 min. Control participants were instructed to take non-steroidal anti-inflammatory drugs as needed. Surveys were used to record pain before and after treatment. We hypothesized that the PowerDot would decrease self-reported pain scores, and decrease non-steroidal anti-inflammatory drug consumption during menses.
UNASSIGNED: Participants experienced a statistically and clinically significant reduction in pain during the Control (-3.52 ± 1.9), Uno (-2.10 ± 1.6), and Duo (-2.19 ± 1.7) cycles (p < 0.001). The doses of non-steroidal anti-inflammatory drugs consumed during the Control cycle (3.5 ± 2.6), was significantly different as compared with that of Uno (1.5 ± 3.0), or Duo (1.1 ± 2.6) (p = 0.004).
UNASSIGNED: Use of a commercial transcutaneous electrical nerve stimulation unit results in significant decrease in pain. Although not as robust as the relief in pain induced by non-steroidal anti-inflammatory drugs, the adverse events of transcutaneous electrical nerve stimulation are minimal in comparison. Therefore, transcutaneous electrical nerve stimulation appears to be a viable alternative to pain relief from
dysmenorrhea.
UNASSIGNED: NCT05178589.
The role of electrical signals for period pain reliefMenstruation, also known as the period, is a cyclicly occurring event in people who are assigned female at birth. Often, the period is associated with abdominal pain that can be debilitating for many. This abdominal pain is typically treated using over-the-counter medications, such as ibuprofen; however, there several noted side effects that can arise from use of such medication. As such, this study aimed to understand if a device (Therabody PowerDot®; Therabody Inc., Los Angeles) that sends an electrical current to pads placed over the abdomen, much like a heating pad, could be used to decrease pain during the period to a similar level as medication. The research team studied three consecutive periods with differing setups: a single, elongated pad, placed on the lower abdomen (Uno), two circular pads placed on the lower abdomen (Duo), or no use of the device, only medication (Control). The researchers analyzed data from 34 individuals. It was found that all three cycles experienced a significant decrease in pain, with the control cycle having a greater decrease in pain than both the Uno and Duo. This study suggests that the electrical stimulation used here can greatly decrease pain during the period, though not as substantial as medication.